People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

A new study published in the Journal of Medical Internet Research has found that regular participation in dance classes can ...

Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

Marc Cohn has taken took Instagram to reveal his hope amid his Parkinson’s disease diagnosis.

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced disease.

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...